Gateway to Typhoid Conjugate Vaccine Introduction in India and Beyond-Programmatic Effectiveness of a Public Sector Typhoid Conjugate Vaccine Campaign in Navi Mumbai.
作者信息
Carey Megan E
机构信息
Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom.
出版信息
Clin Infect Dis. 2023 Jul 5;77(1):145-147. doi: 10.1093/cid/ciad134.
Abstract
摘要
相似文献
1
Gateway to Typhoid Conjugate Vaccine Introduction in India and Beyond-Programmatic Effectiveness of a Public Sector Typhoid Conjugate Vaccine Campaign in Navi Mumbai.印度及其他地区引入伤寒结合疫苗的门户——孟买新市镇公共部门伤寒结合疫苗接种运动的项目成效
Clin Infect Dis. 2023 Jul 5;77(1):145-147. doi: 10.1093/cid/ciad134.
2
Field Effectiveness of a Typhoid Conjugate Vaccine: The 2018 Navi Mumbai Pediatric TCV Campaign.伤寒结合疫苗的现场有效性：2018年孟买新市镇儿科伤寒结合疫苗接种活动
Am J Trop Med Hyg. 2024 Aug 13;111(4):848-852. doi: 10.4269/ajtmh.24-0181. Print 2024 Oct 2.
3
Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India.印度那瓦西瓦市小儿伤寒结合疫苗接种运动的规划效果。
Clin Infect Dis. 2023 Jul 5;77(1):138-144. doi: 10.1093/cid/ciad132.
4
Decision Making and Implementation of the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018.2018 年，印度那格浦尔市首次在公共部门引入伤寒结合疫苗的决策与实施。
Clin Infect Dis. 2020 Jul 29;71(Suppl 2):S172-S178. doi: 10.1093/cid/ciaa597.
5
Evaluation of Vaccine Safety After the First Public Sector Introduction of Typhoid Conjugate Vaccine-Navi Mumbai, India, 2018.评价伤寒疫苗在印度那格浦尔市首次纳入公共卫生系统后的安全性。
Clin Infect Dis. 2021 Aug 16;73(4):e927-e933. doi: 10.1093/cid/ciab059.
6
Retrospective Review of Blood Culture-Confirmed Cases of Enteric Fever in Navi Mumbai, India: 2014-2018.印度那瓦西孟血液培养确认肠热病病例的回顾性研究：2014-2018 年。
Am J Trop Med Hyg. 2023 Aug 7;109(3):571-574. doi: 10.4269/ajtmh.23-0102. Print 2023 Sep 6.
7
Madagascar should introduce typhoid conjugate vaccines now.马达加斯加现在应该引入伤寒结合疫苗。
Lancet. 2018 Oct 13;392(10155):1309-1310. doi: 10.1016/S0140-6736(18)31882-8.
8
The need & the issues related to new-generation typhoid conjugate vaccines in India.印度新一代伤寒结合疫苗的需求和相关问题。
Indian J Med Res. 2020 Jan;151(1):22-34. doi: 10.4103/ijmr.IJMR_1890_17.
9
Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?用于预防儿童伤寒热的Vi多糖-蛋白质结合疫苗：希望还是炒作？
Expert Rev Vaccines. 2007 Jun;6(3):293-5. doi: 10.1586/14760584.6.3.293.
10
A forecast of typhoid conjugate vaccine introduction and demand in typhoid endemic low- and middle-income countries to support vaccine introduction policy and decisions.预测伤寒结合疫苗在伤寒地方性中低收入国家的引入和需求，以支持疫苗引入政策和决策。
Hum Vaccin Immunother. 2017 Sep 2;13(9):2017-2024. doi: 10.1080/21645515.2017.1333681. Epub 2017 Jun 12.
引用本文的文献
1
Intranasal immunization of mice with chimera of Salmonella Typhi protein elicits protective intestinal immunity.用伤寒沙门氏菌蛋白嵌合体对小鼠进行鼻内免疫可引发保护性肠道免疫。
NPJ Vaccines. 2024 Feb 6;9(1):24. doi: 10.1038/s41541-024-00812-4.
本文引用的文献
1
Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000 Typhi genomes.全球伤寒沙门氏菌病原体的多样性和抗药性：来自 13000 个伤寒菌基因组的元分析研究
Elife. 2023 Sep 12;12:e85867. doi: 10.7554/eLife.85867.
2
Using Typhoid Conjugate Vaccines to Prevent Disease, Promote Health Equity, and Counter Drug-Resistant Typhoid Fever.使用伤寒结合疫苗预防疾病、促进健康公平并应对耐药性伤寒热。
Open Forum Infect Dis. 2023 Jun 2;10(Suppl 1):S6-S12. doi: 10.1093/ofid/ofad022. eCollection 2023 May.
3
Delivery cost of the first public sector introduction of typhoid conjugate vaccine in Navi Mumbai, India.印度新孟买首次在公共部门引入伤寒结合疫苗的交付成本。
PLOS Glob Public Health. 2023 Jan 4;3(1):e0001396. doi: 10.1371/journal.pgph.0001396. eCollection 2023.
4
Programmatic Effectiveness of a Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India.印度那瓦西瓦市小儿伤寒结合疫苗接种运动的规划效果。
Clin Infect Dis. 2023 Jul 5;77(1):138-144. doi: 10.1093/cid/ciad132.
5
Typhoid conjugate vaccine effectiveness in Malawi: evaluation of a test-negative design using randomised, controlled clinical trial data.在马拉维评估伤寒结合疫苗的效果：使用随机对照临床试验数据的阴性病例对照设计评估
Lancet Glob Health. 2023 Jan;11(1):e136-e144. doi: 10.1016/S2214-109X(22)00466-1. Epub 2022 Nov 25.
6
Safety and immunogenicity of a typhoid conjugate vaccine among children aged 9 months to 12 years in Malawi: a nested substudy of a double-blind, randomised controlled trial.马拉维 9 月龄至 12 岁儿童中伤寒结合疫苗的安全性和免疫原性：一项双盲、随机对照试验的嵌套子研究。
Lancet Glob Health. 2022 Sep;10(9):e1326-e1335. doi: 10.1016/S2214-109X(22)00275-3.
7
The international and intercontinental spread and expansion of antimicrobial-resistant Salmonella Typhi: a genomic epidemiology study.国际和洲际传播和扩展的抗微生物耐药伤寒沙门氏菌：基因组流行病学研究。
Lancet Microbe. 2022 Aug;3(8):e567-e577. doi: 10.1016/S2666-5247(22)00093-3. Epub 2022 Jun 21.
8
Effectiveness of typhoid conjugate vaccine in Zimbabwe used in response to an outbreak among children and young adults: A matched case control study.津巴布韦针对儿童和青年成年人爆发疫情使用伤寒结合疫苗的效果：一项匹配病例对照研究。
Vaccine. 2022 Jul 29;40(31):4199-4210. doi: 10.1016/j.vaccine.2022.04.093. Epub 2022 Jun 9.
9
Estimating the effect of vaccination on antimicrobial-resistant typhoid fever in 73 countries supported by Gavi: a mathematical modelling study.评估 Gavi 支持的 73 个国家疫苗接种对耐药性伤寒的影响：一项数学建模研究。
Lancet Infect Dis. 2022 May;22(5):679-691. doi: 10.1016/S1473-3099(21)00627-7. Epub 2022 Feb 3.
10
Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial.在尼泊尔进行的伤寒结合疫苗的有效性：3 期、随机、对照试验的最终结果。
Lancet Glob Health. 2021 Nov;9(11):e1561-e1568. doi: 10.1016/S2214-109X(21)00346-6.
Zotero 插件